Related Experiment Video
Updated: Aug 19, 2026

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Microalbuminuria
J Segura1, L M Ruilope, J L Rodicio
1Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
Insights
Microalbuminuria detection is crucial for predicting cardiovascular and renal risk in hypertensive patients. Early identification aids in selecting targeted therapies to prevent adverse cardiovascular events.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Microalbuminuria is a known predictor of cardiovascular and renal risk in diabetic, hypertensive, and general populations.
- Approximately 40% of essential hypertension patients exhibit microalbuminuria, especially those with uncontrolled blood pressure.
- Albuminuria serves as a marker for renal damage and cardiovascular risk in essential hypertension.
Purpose of the Study:
- To evaluate the relevance of microalbuminuria detection in essential hypertension for selecting therapeutic strategies.
- To assess microalbuminuria as a tool for defining cardiovascular risk profiles and stratifying prognosis in hypertensive patients.
- To explore the role of ACE-inhibitors and angiotensin II receptor antagonists in managing microalbuminuria.
Main Methods:
- Observational analysis of microalbuminuria prevalence in essential hypertension.
- Assessment of microalbuminuria as a prognostic marker for renal and cardiovascular risk.
- Review of therapeutic interventions, including ACE-inhibitors and ARBs, for microalbuminuria reduction.
Main Results:
- Microalbuminuria is prevalent in uncontrolled essential hypertension, indicating increased risk.
- Microalbuminuria effectively stratifies prognosis related to renal and cardiovascular outcomes.
- ACE-inhibitors and ARBs demonstrate efficacy in reducing microalbuminuria.
Conclusions:
- Microalbuminuria is a valuable, simple method for cardiovascular risk stratification in hypertensive patients.
- Routine determination of microalbuminuria can guide therapeutic choices for essential hypertension.
- Targeted therapies like ACE-inhibitors and ARBs are effective in managing microalbuminuria and associated risks.
Abstract:
The capacity of microalbuminuria to predict an increased cardiovascular and renal risk is well established in diabetic patients, as well as in essential hypertensive patients and in general population. Detection of microalbuminuria could then be relevant to select specific therapeutic strategies for reducing or preventing cardiovascular events in patients with essential hypertension. Microalbuminuria is detectable in almost 40% of the population with established hypertension, particularly in those patients not controlled satisfactorily with medical therapy. Albuminuria may represent a marker of renal damage and cardiovascular risk in essential hypertension. Microalbuminuria seems to represent a simple and reproducible method to better define cardiovascular risk profile in the hypertensive patient and to stratify the prognosis in relation to renal and cardiovascular risk. ACE-inhibitors and more recently angiotensin II receptor antagonists seem to exhibit a more market capacity to reduce microalbuminuria in patients with essential hypertension or diabetes mellitus. Determination of this parameter in daily clinical practice could facilitate the stratification of risk as well as the choice of therapy in essential hypertensive patients.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Hyperglycemia